Clinical Trial Update: Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 adjuvant chemotherapy trial for high-risk uterine leiomyosarcoma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Uterine Cancer

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Leiomyosarcoma, Uterine Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2014-12-01